Impact Journals LLC Feb 10 2026 A new research paper was published in Volume 13 of  Oncoscience  on January 28, 2026, titled "Dual targeting of oncogenic microtubules and mitochondria in PDAC." In this study led by first author Michael W. Spinrad with corresponding author, Evan S. Glazer from The University of Tennessee Health Science Center, researchers found that an experimental compound, SB-216, reduced the growth of pancreatic ductal adenocarcinoma (PDAC) cells. The research addresses a